Arborcandins A, B, C, E and F, novel 1,3-β-glucan synthase inhibitors: Production and biological activity

Journal of Antibiotics

Volumn 53, Issue 10, 2000, Pages 1108-1116

  Ohyama, T ^a   Kurihara, Y ^a   Ono, Y ^a   Ishikawa, T ^a   Miyakoshi, S ^a   Hamano, K ^a   Arai, M ^a   Suzuki, T ^a   Igari, H ^a   Suzuki, Y ^a   Inukai, M ^a  

^a Lead Discovery Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; AMPHOTERICIN B; ANTIFUNGAL AGENT; ARBORCANDIN A; ARBORCANDIN B; ARBORCANDIN C; ARBORCANDIN D; ARBORCANDIN E; ARBORCANDIN F; CARBON 14; CYCLOPEPTIDE; EDETIC ACID; ENZYME INHIBITOR; FLUCONAZOLE; GLUCAN SYNTHASE; GUANOSINE TRIPHOSPHATE; LEUCINE; PNEUMOCANDIN A; PNEUMOCANDIN B; PNEUMOCANDIN DERIVATIVE; TRITIUM; TROMETAMOL; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CONFORMATION; DRUG ISOLATION; DRUG POTENCY; ENZYME INHIBITION; FUNGICIDAL ACTIVITY; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS;

EID: 17044457753     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.1108     Document Type: Article

References (18)

1. Human mycoses: Drugs and targets for emerging pathogens
2. Current and future antifungal therapy: New targets for antifungal agents
3. Clinical cellular, and molecular factors that contribute to antifungal drug resistance
4. Fungal cell walls: Their structure, biosynthesis and biotechnological aspects
5. Antibiotics that inhibit fungal cell wall development
6. Characterization and gene cloning of 1,3-β-glucan synthase from Saccharomyces cerevisiae
7. Cloning of the Candida albicans homologue of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in β-1,3-glucan synthase
8. Fungal 1,3-β-glucan synthase
9. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-β-D-glucan synthase
10. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase
11. In vitro antifungal activities and in vivo efficacies of 1,3-β-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin
12. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species
13. In vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B deoxycholate on human polymorphonuclear leucocytes
14. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
15. Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans
16. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
17. A glucan synthase FKS1 homologue in Cryptococcus neoformans is single copy and encodes an essential function